Results 151 to 160 of about 35,117 (307)

Hexahydrocannabinol and Hexahydrocannabiphorol Poisonings: Data From the Czech Toxicology Information Centre and Effects of Legislative Changes

open access: yesPharmacology Research &Perspectives, Volume 13, Issue 5, October 2025.
Development in the number of HHC and HHC‐P intoxications before and after the government ban on sales. ABSTRACT Hexahydrocannabinol, a hydrogenated derivative of cannabinol, first came to the Czech Toxicological Information Centre (TIC) following reports of poisonings in May 2022. We conducted a retrospective observational study examining self‐reported
Michal Čečrle   +3 more
wiley   +1 more source

Antiemetic use among pregnant women in the United States: the escalating use of ondansetron

open access: yesPharmacoepidemiology and Drug Safety, 2017
L. Taylor   +8 more
semanticscholar   +1 more source

If a Child Vomits After an Oral Medication—Should We Re‐Dose or Not?

open access: yesActa Paediatrica, Volume 114, Issue 10, Page 2506-2510, October 2025.
ABSTRACT Vomiting after oral administration of medication is common in children. Despite this, there is a lack of formal guidelines and recommendations on this topic. This article is intended for doctors and nurses who treat children to support the management of this everyday clinical dilemma.
Christiane A. Garnemark   +5 more
wiley   +1 more source

Olanzapine plus triple antiemetic therapy for prevention of carboplatin-induced nausea: a pooled analysis of two clinical trials. [PDF]

open access: yesBMC Cancer
Kojima S   +17 more
europepmc   +1 more source

Comparison of ondansentron versus ondansentron plus methylprednisolone as antiemetic prophylaxis during cisplatin-containing chemotherapy

open access: bronze, 1994
Νicolas Tsavaris   +5 more
openalex   +1 more source

Antiemetic Prophylaxis as a Marker of Health Care Disparities in the National Anesthesia Clinical Outcomes Registry

open access: yesAnesthesia and Analgesia, 2017
M. Andreae   +4 more
semanticscholar   +1 more source

Development of an Artificial Intelligence Powered Medication Risk Score Calculator Application

open access: yesBasic &Clinical Pharmacology &Toxicology, Volume 137, Issue 4, October 2025.
ABSTRACT The publication explores the development of the Augmented Medication Risk Score (AUGMERIS) calculator, a web application supported by artificial intelligence, designed to automate the evaluation of medication therapies with the Danish Medication Risk Score (MERIS) method.
Ádám Bertalan   +7 more
wiley   +1 more source

Identification of high-risk age groups for cisplatin-induced nausea and vomiting in young patients with sarcoma. [PDF]

open access: yesJ Pharm Health Care Sci
Soejima A   +6 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy